FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

ILIAC CREST BONE MARROW ASPIRATION NEEDLE

K Number: K953082 · Decision Sep 22, 1995
Classifications
1
FEI Numbers
113
Registration Numbers
113
Same Product Code
47
Applicant Total
505
Review Days
81

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ILIAC CREST BONE MARROW ASPIRATION NEEDLE
K Number
K953082
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
878.4800
Medical Specialty
General, Plastic Surgery
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Baxter Healthcare Corp
Date Received
July 3, 1995
Decision Date
September 22, 1995
Product Code
GDM
Advisory Committee
General, Plastic Surgery
Review Advisory Committee
SU
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GDM Needle, Aspiration And Injection, Reusable

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GDM), ordered by most recent decision date.

View all

Other Clearances by Baxter Healthcare Corp

K Number Device Name
K190910 PrisMax System Version 2
K163530 PrisMax Control Unit
K130531 ULTRAFUSE
K132734 NEUTRAL LUER ACTIVATED DEVICE (ONE-LINK NEEDLE-FREE IV CONNECTOR) AND EXTENSION SETS
K130245 LARGE BORE STOPCOCK WITH ROTATING MALE LUER LOCK/LARGE BORE STOPCOCK WITH EXTENSION SET, GANG LARGE BORE STOPCOCK MANIFO
K123874 INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S
K123868 INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET
K121092 FLOWEASE [SUBCUTANEOUS] INFUSION SET
K113227 NON-DEHP MICRO-VOLUME EXTENSION SET WITH 0.22 MICRON FILTER
K111217 ADDITIVE CAP
Search all 505 clearances from Baxter Healthcare Corp →